Real-world experience with fluocinolone acetonide intravitreal implant in patients with diabetic macular edema

CONCLUSION: FAc implant provides a substantial long-term functional and anatomical benefit when used as second-line treatment in eyes with DME. IOP rise can be adequately managed with topical agents although some eyes may require IOP-lowering surgery.PMID:38396370 | DOI:10.1177/11206721241235266

Source: European Journal of Ophthalmology - February 24, 2024 Category: Opthalmology Authors: Luigi Capone Pietro Airaghi Pasquale Aragona Nicol ò Castellino Maria Vittoria Cicinelli Francesco Ciucci Michele Coppola Cristiano De Gaetano Rosangela Lattanzio Massimo Lorusso Martina Maceroni Maria Elena Malvasi Luisa Marco Michele Marraffa Gaia Mart Source Type: research